[go: up one dir, main page]

MX2009004983A - Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion. - Google Patents

Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.

Info

Publication number
MX2009004983A
MX2009004983A MX2009004983A MX2009004983A MX2009004983A MX 2009004983 A MX2009004983 A MX 2009004983A MX 2009004983 A MX2009004983 A MX 2009004983A MX 2009004983 A MX2009004983 A MX 2009004983A MX 2009004983 A MX2009004983 A MX 2009004983A
Authority
MX
Mexico
Prior art keywords
compositions containing
production
substituted pyrazoles
pyrazoles
substituted
Prior art date
Application number
MX2009004983A
Other languages
English (en)
Inventor
Michel Tabart
Jacques Mauger
Anil Nair
Kirsten Bjergarde
Marcel Patek
Mark Dodson
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of MX2009004983A publication Critical patent/MX2009004983A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La invención se refiere a nuevos compuestos químicos, particularmente a pirazoles sustituidos, a composiciones que los contienen, y a su uso como fármacos.
MX2009004983A 2006-11-10 2007-11-09 Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion. MX2009004983A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0609812A FR2908409B1 (fr) 2006-11-10 2006-11-10 Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation
PCT/FR2007/001851 WO2008065282A2 (fr) 2006-11-10 2007-11-09 Pyrazoles substituees, compositions les contenant, procede de fabrication et utilisation

Publications (1)

Publication Number Publication Date
MX2009004983A true MX2009004983A (es) 2009-05-22

Family

ID=38169388

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004983A MX2009004983A (es) 2006-11-10 2007-11-09 Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.

Country Status (39)

Country Link
US (3) US7989439B2 (es)
EP (1) EP2091920B1 (es)
JP (1) JP5538893B2 (es)
KR (1) KR20090083456A (es)
CN (1) CN101553473B (es)
AR (1) AR063638A1 (es)
AU (1) AU2007327423B2 (es)
BR (1) BRPI0718999A2 (es)
CA (1) CA2667846A1 (es)
CL (1) CL2007003251A1 (es)
CO (1) CO6190516A2 (es)
CR (1) CR10749A (es)
CY (1) CY1116000T1 (es)
DK (1) DK2091920T3 (es)
DO (1) DOP2009000088A (es)
EA (1) EA019454B1 (es)
EC (1) ECSP099312A (es)
ES (1) ES2528385T3 (es)
FR (1) FR2908409B1 (es)
HN (1) HN2009000856A (es)
HR (1) HRP20150070T1 (es)
IL (1) IL198328A0 (es)
MA (1) MA30972B1 (es)
MX (1) MX2009004983A (es)
MY (1) MY147502A (es)
NI (1) NI200900078A (es)
NO (1) NO20091990L (es)
NZ (1) NZ576709A (es)
PE (2) PE20081162A1 (es)
PL (1) PL2091920T3 (es)
PT (1) PT2091920E (es)
SI (1) SI2091920T1 (es)
SV (1) SV2009003253A (es)
TN (1) TN2009000155A1 (es)
TW (1) TW200829556A (es)
UA (1) UA97965C2 (es)
UY (1) UY30707A1 (es)
WO (1) WO2008065282A2 (es)
ZA (1) ZA200903560B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858323B2 (en) * 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
FR2947546B1 (fr) * 2009-07-03 2011-07-01 Sanofi Aventis Derives de pyrazoles, leur preparation et leur application en therapeutique
AR079967A1 (es) * 2010-01-26 2012-02-29 Sanofi Aventis Derivados de acido 3-heteroaroilamino-propionico sustituidos con oxigeno y su uso como productos farmaceuticos
TWI523844B (zh) * 2011-01-26 2016-03-01 賽諾菲公司 經胺基取代之３－雜芳醯基胺基－丙酸衍生物及其作為藥物之用途
CN102432639B (zh) * 2011-09-30 2013-11-06 山东大学 1-(2-羟基-3-(苯氨基)丙基)-3-二茂铁基-1h-吡唑-5-甲酸乙酯化合物及其应用
MD20150035A2 (ro) 2012-11-02 2015-10-31 Pfizer Inc. Inhibitori de tirozinkinaza Bruton
RU2017134379A (ru) 2015-03-25 2019-04-03 Новартис Аг Формилированные n-гетероциклические производные в качестве ингибиторов fgfr4
CN107619388A (zh) * 2016-07-13 2018-01-23 南京天印健华医药科技有限公司 作为fgfr抑制剂的杂环化合物
CN107840842A (zh) 2016-09-19 2018-03-27 北京天诚医药科技有限公司 炔代杂环化合物、其制备方法及其在医药学上的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878714B2 (en) * 2001-01-12 2005-04-12 Amgen Inc. Substituted alkylamine derivatives and methods of use
CA2445357A1 (en) * 2001-04-27 2002-11-07 Vertex Pharmaceuticals Incorporated Pyrazole derived kinase inhibitors
CA2522079A1 (en) * 2003-04-16 2004-11-04 Astrazeneca Ab Quinazoline derivatives for treatment of cancer
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
NZ544756A (en) * 2003-07-22 2009-09-25 Astex Therapeutics Ltd 3,4-Disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
JP2008505167A (ja) * 2004-07-05 2008-02-21 アステックス、セラピューティックス、リミテッド 医薬組成物
US20080261952A1 (en) * 2004-08-16 2008-10-23 Jason Bloxham Aryl Urea Derivatives for Treating Obesity
US20100160324A1 (en) * 2004-12-30 2010-06-24 Astex Therapeutics Limited Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
MX2007008809A (es) * 2005-01-21 2007-09-07 Astex Therapeutics Ltd Combinaciones de inhibidores de pirazol cinasa y otros agentes antitumor.
AR053662A1 (es) * 2005-01-21 2007-05-16 Astex Therapeutics Ltd Compuestos de pirazol inhibidores de la actividad quinasa cdk y gsk
EP1683796A1 (en) * 2005-01-24 2006-07-26 Schering Aktiengesellschaft Pyrazolopyridines, their preparation and their medical use
FR2947546B1 (fr) * 2009-07-03 2011-07-01 Sanofi Aventis Derives de pyrazoles, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
EA019454B1 (ru) 2014-03-31
WO2008065282A2 (fr) 2008-06-05
CN101553473B (zh) 2013-06-05
CY1116000T1 (el) 2017-01-25
SI2091920T1 (sl) 2015-02-27
PL2091920T3 (pl) 2015-04-30
ZA200903560B (en) 2010-08-25
DOP2009000088A (es) 2013-06-15
MY147502A (en) 2012-12-14
EP2091920A2 (fr) 2009-08-26
CN101553473A (zh) 2009-10-07
MA30972B1 (fr) 2009-12-01
JP5538893B2 (ja) 2014-07-02
UY30707A1 (es) 2008-07-03
AR063638A1 (es) 2009-02-04
CO6190516A2 (es) 2010-08-19
ES2528385T3 (es) 2015-02-09
NI200900078A (es) 2010-01-27
NO20091990L (no) 2009-06-02
AU2007327423B2 (en) 2012-09-06
US8420824B2 (en) 2013-04-16
EP2091920B1 (fr) 2014-10-22
NZ576709A (en) 2011-08-26
IL198328A0 (en) 2010-02-17
UA97965C2 (ru) 2012-04-10
US20090291984A1 (en) 2009-11-26
US20110237641A1 (en) 2011-09-29
HN2009000856A (es) 2011-10-19
DK2091920T3 (en) 2015-01-26
SV2009003253A (es) 2009-10-27
CA2667846A1 (fr) 2008-06-05
CL2007003251A1 (es) 2009-08-07
HK1137988A1 (en) 2010-08-13
HRP20150070T1 (hr) 2015-02-27
TW200829556A (en) 2008-07-16
AU2007327423A1 (en) 2008-06-05
PE20081162A1 (es) 2008-10-02
WO2008065282A3 (fr) 2008-07-31
PE20121152A1 (es) 2012-09-07
JP2010509297A (ja) 2010-03-25
ECSP099312A (es) 2009-06-30
TN2009000155A1 (fr) 2010-10-18
FR2908409A1 (fr) 2008-05-16
CR10749A (es) 2009-07-23
BRPI0718999A2 (pt) 2014-02-25
US20110237801A1 (en) 2011-09-29
EA200970472A1 (ru) 2009-10-30
US7989439B2 (en) 2011-08-02
PT2091920E (pt) 2015-02-05
KR20090083456A (ko) 2009-08-03
FR2908409B1 (fr) 2009-01-09
US8410286B2 (en) 2013-04-02

Similar Documents

Publication Publication Date Title
MY153915A (en) Organic compounds
MX2011005934A (es) Compuestos organicos.
SI1888541T1 (sl) Benzo(d)izoksazol-3-il-aminske spojine in njihova uporaba kot ligandi vaniloidnega receptorja
MX2009003382A (es) Derivados de sulfonamidas sustituidos.
MX2011009369A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
PL1891004T3 (pl) Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
MX2011011661A (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
MX2009004983A (es) Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
MX2007003108A (es) Compuestos imidazo-3-il-amina sustituidos y biciclicos.
UA95644C2 (ru) Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
MX2009010047A (es) Compuestos quimicos.
MY150542A (en) Cmet inhibitors
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
WO2008046581A3 (de) Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln
MX2007008790A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso.
MX2012004780A (es) Inhibidores de akt.
MX2011008825A (es) 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
TW200738627A (en) Trialkylsilyl-indoles
MX2011008662A (es) 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3.
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
SG158091A1 (en) Imidazoazepinone compounds
JO2770B1 (en) Organic compounds
MX2009000768A (es) Lactamas macrociclicas.
MX2008011576A (es) Compuestos de imidazo[2,1-b]tiazol sustituidos y su uso para la produccion de farmacos.
MX2009010176A (es) Derivados de aza-adamantano 4-substituidos y metodos de uso de los mismos.

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration